HAEMONETICS
HAEMONETICS operates in Diversified Metals & Mining.
HAEMONETICS (HAZ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.056x
Based on the latest financial reports, HAEMONETICS (HAZ) has a cash flow conversion efficiency ratio of 0.056x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€48.82 Million) by net assets (€878.85 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
HAEMONETICS - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how HAEMONETICS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
HAEMONETICS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of HAEMONETICS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Longevity Health Holdings, Inc.
NASDAQ:XAGE
|
0.360x |
|
Spermosens AB (publ)
F:9R5
|
-0.075x |
|
RJK Explorations Ltd
PINK:RJKAF
|
0.135x |
|
Burcon NutraScience Corp
PINK:BRCNF
|
0.640x |
|
Movinn AS
CO:MOVINN
|
0.254x |
|
Iiot-Oxys Inc
PINK:ITOX
|
0.015x |
|
Thai Enger Holding Public Company Limited
BK:TIGER
|
0.009x |
|
New World Resources Limited
PINK:NWCBF
|
-0.005x |
Annual Cash Flow Conversion Efficiency for HAEMONETICS (2017–2024)
The table below shows the annual cash flow conversion efficiency of HAEMONETICS from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-03-31 | €959.96 Million | €181.75 Million | 0.189x | -43.28% |
| 2023-03-31 | €818.00 Million | €273.06 Million | 0.334x | +45.22% |
| 2022-03-31 | €749.42 Million | €172.26 Million | 0.230x | +54.57% |
| 2021-03-31 | €731.67 Million | €108.81 Million | 0.149x | -44.82% |
| 2020-03-31 | €587.11 Million | €158.22 Million | 0.269x | +13.00% |
| 2019-03-31 | €667.87 Million | €159.28 Million | 0.238x | -18.56% |
| 2018-03-31 | €752.43 Million | €220.35 Million | 0.293x | +35.59% |
| 2017-03-31 | €739.61 Million | €159.74 Million | 0.216x | -- |